comparemela.com

Latest Breaking News On - Thomas kudsk larsen - Page 8 : comparemela.com

Positive topline results from pivotal XTEND-Kids phase 3 study of efanesoctocog alfa in children under 12 years of age with haemophilia A: Swedish Orphan Biovitrum AB

Sobi publishes Q4 and FY 2022 report: a good year and a solid future

/PRNewswire/ Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the fourth quarter and full year of 2022 Fourth quarter 2022 Total.

vimarsana © 2020. All Rights Reserved.